期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 107, 期 29, 页码 12901-12906出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1001499107
关键词
chemokine; signaling; apoptosis
资金
- National Institutes of Health [AR051476]
- Yale Core Center for Musculoskeletal Diseases [P30 AR04603211]
G protein-coupled receptor-regulated PI3K gamma is abundantly expressed in myeloid cells and has been implicated as a promising drug target to treat various inflammatory diseases. However, its role in bone homeostasis has not been investigated, despite the fact that osteoclasts are derived from myeloid lineage. We therefore carried out thorough bone phenotypic characterization of a PI3K gamma-deficient mouse line and found that PI3K gamma-deficient mice had high bone mass. Our analyses further revealed that PI3K gamma deficiency did not affect bone formation because no significant changes in osteoblast number and bone formation rate were observed. Instead, the lack of PI3K gamma was associated with decreased bone resorption, as evidenced by decreased osteoclast number in vivo and impaired osteoclast formation in vitro. The decreased osteoclast formation was accompanied by down-regulated expression of osteoclastogenic genes, compromised chemokine receptor signaling, and an increase in apoptosis during osteoclast differentiation. Together, these data suggest that PI3K gamma regulates bone homeostasis by modulating osteoclastogenesis. Our study also suggests that inhibition of PI3K gamma, which is being considered as a potential therapeutic strategy for treating chronic inflammatory disorders, may result in an increase in bone mass.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据